A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 120.00
GOOG 804.61
MSFT 62.53
FB 127.87
BAC 22.05

Recently Added

RCL 84.99
GFF 24.65
RUTH 17.25
LAD 101.67
SF 48.54

Gaining Speed

RCL 84.99
RUTH 17.25
GFF 24.65
CCL 53.09
KMX 66.47

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!